Available in your choice of English or Arabic
Danish pharma giant Novo Nordisk is in the process of registering four new meds in Egypt to introduce them by 2022, the company’s deputy chairman in Egypt Ayman Hassan told the local press, without providing further details on the products.
Israel’s Arkia shifts some flights to Egypt as airspace tightens…
Plus: Incolease taps securitization market with debut EGP 2 bn…
PE and VC-backed companies were already pivoting to local exchanges…
Telda claims users can sell a position and immediately spend…
Queue
Egypt Edition 
UAE Edition 
Saudi Edition 
MENA <> India Corridors 
Logistics (MENA) 
Climate (MENA) 
Share
Read Full Issue